THE INVESTOR

메뉴열기
September 24, 2018

CKD Bio to invest W28.5b in facilities

PUBLISHED : September 14, 2018 - 14:22

UPDATED : September 14, 2018 - 14:22

  • 본문폰트 작게
  • 본문폰트 크게
  • 페이스북
  • 트위터
  • sms

[DISCLOSURE] Chongkundang Bio (063160) said on Sept. 14 that it has decided to invest 28.5 billion won (US$25.48 million) in new facilities for probiotics to increase manufacturing capacity and to build fill and finish facilities. It will also build microbiome facilities. 

This amounts to 20.04 percent of its equity capital and the investment period is until Nov. 30, 2019.

By Hwang You-mee (glamazon@heraldcorp.com)

  • 페이스북
  • 트위터
  • sms
최상단으로
Herald Corporation|CEO : Kwon Chung Won
Chief Privacy Officer & Juvenile Protection Manager : Shin Chang Hoon
Company Registration No. 104-81-06004
Mail-Order Business Registration 2016 - Seoul Yongsan - 00590
Huam-ro 4-gil 10, Yongsan-gu, Seoul, Korea
T : +82-2-727-0615|Business info
COPYRIGHT HERALD CORPORATION. ALL RIGHTS RESERVED.